NCT02269462View on ClinicalTrials.gov

A Study to Evaluate the Effects of Genetic Factors on the Pharmacokinetics of Antiretroviral Drugs During Pregnancy and Lactation

CompletedOBSERVATIONAL
Enrollment

460

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

November 30, 2013

Conditions
HIVPregnancyBreastfeeding
Interventions
DRUG

Efavirenz

600 mg once daily in combination with other drugs (e.g. tenofovir and emtricitabine)

DRUG

Nevirapine

200 mg twice daily in combination with other drugs (e.g. tenofovir and emtricitabine)

Trial Locations (3)

Unknown

St Monica's Hospital, Adikpo

Bishop Murray Medical Centre, Makurdi

St Mary's Hospital, Okpoga

All Listed Sponsors
collaborator

University of Liverpool

OTHER

collaborator

Obafemi Awolowo University Teaching Hospital

OTHER

lead

Adeniyi Olagunju

OTHER

NCT02269462 - A Study to Evaluate the Effects of Genetic Factors on the Pharmacokinetics of Antiretroviral Drugs During Pregnancy and Lactation | Biotech Hunter | Biotech Hunter